MedPath

Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study

Not Applicable
Recruiting
Conditions
Smoking Cessation
Interventions
Other: Mindfulness
Device: Transcranial Direct Current Stimulation (tDCS)
Other: Sham - Transcranial Direct Current Stimulation (tDCS)
Registration Number
NCT05460676
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

The study aims to evaluate the feasibility of using Dorsolateral Prefrontal Cortex (DLPFC) Transcranial Direct Current Stimulation (tDCS) as a tool to decreasing distress and cigarette smoking. 46 participants currently smoking cigarettes, and seeking to decrease cigarette use will be recruited.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
46
Inclusion Criteria
  • 21-75 years old
  • smoke ≥10 cigarettes per day
  • mild to moderate distress (K10 scores 10-35)
  • access to a reliable internet connection
  • all prescription medications stable for ≥ 1 month prior to enrollment and throughout the trial, and approved by the Study Physician
Exclusion Criteria
  • Current suicidal ideation
  • Current use of smoking cessation medication (e.g., varenicline)
  • Current use of inhaled products (other than cigarettes) which may influence exhaled carbon monoxide measures (e.g. smoking cannabis, vaping)
  • History of seizure disorder, recent (<5 years) seizure history, cerebrovascular accident, neurodegenerative disease, or traumatic brain injury
  • Currently receiving chemotherapy or radiation
  • Presence of metal objects in the head/neck
  • Any skin disorder or skin sensitive area near stimulation locations

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham tDCS + MindfulnessMindfulness-
Sham tDCS + MindfulnessSham - Transcranial Direct Current Stimulation (tDCS)-
Active tDCS + MindfulnessMindfulness-
Active tDCS + MindfulnessTranscranial Direct Current Stimulation (tDCS)-
Primary Outcome Measures
NameTimeMethod
Feasibility and Tolerability Questionnaire (FTQ) score1 month

The FTQ is a questionnaire is a 10 question survey which will be used to determine the ease and comfort of device use. Each question will be rated on a scale of 1 - 10, with 1 indicating the greatest difficulty or discomfort, and 10 indicating the greatest ease or tolerability. Questions for which the population average is greater than or equal to 5 will be deemed well tolerated.

Secondary Outcome Measures
NameTimeMethod
Weekly cigarette use1 month

The timeline follow back questionnaire (TLFB) is a self report questionnaire which asks the participant to state the number of cigarettes they have smoked each day. The total number of cigarettes smoked each week will be compiled for each participant. weekly totals will be compared between the 2 arms of the study.

Kessler Psychological Distress Scale (K10) Score1 month

K10 is a 10-item questionnaire intended to yield a global measure of distress based on questions about anxiety and depressive symptoms that a person has experienced in the most recent 4 week period. Each question is given a score between 1 (none of the time) to 5 (all of the time). The total score ranges from 10 to 50. People with scores \< 20 are likely to be well, 20-24 are likely to have a mild mental disorder, 25-29 are likely to have moderate mental disorder, and \> 30 are likely to have a severe mental disorder.

Trial Locations

Locations (1)

Wake Forest University Health Sciences

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath